LFCR
Lifecore Biomedical, Inc. \De\Company with tickers: LFCR
CIK
1005286
CUSIP
514766104
Shares Outstanding
37,509,407
Website
https://www.lifecore.com
13F Activity (30d)
2 filings
1 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Christopher S. Kiper | Series A Preferred Director | Appointed | 2026-06-05 |
| Jason Aryeh | Series A Preferred Director | Appointed | 2026-06-05 |
| Joshua E. Schechter | Director | Appointed | 2026-06-05 |
| Nelson Obus | Director | Appointed | 2026-06-05 |
| Matthew E. Korenberg | Director | Appointed | 2026-06-05 |
| Paul Josephs | Director | Appointed | 2026-06-05 |
| Paul H. Johnson | Director | Appointed | 2026-06-05 |
| Humberto C. Antunes | Director | Appointed | 2026-06-05 |
| Katrina L. Houde | Director | Appointed | 2026-06-05 |